View in EDS HTML Full Text PDF Full Text

[177Lu] Lu-PSMA-617 treatment for metastatic castration-resistant prostate cancer (mCRPC) with cerebral and cerebellar metastases.

Saved in:
Bibliographic Details
Title: [177Lu] Lu-PSMA-617 treatment for metastatic castration-resistant prostate cancer (mCRPC) with cerebral and cerebellar metastases.
Authors: Belge Bilgin, Gokce1 (AUTHOR) belgebilgin.gokce@mayo.edu, Bilgin, Cem1 (AUTHOR), Burkett, Brian J.1 (AUTHOR), Thorpe, Matthew P.1 (AUTHOR), Packard, Ann T.1 (AUTHOR), Fidanli, Fatma1 (AUTHOR), Childs, Daniel S.2 (AUTHOR), Muniz, Miguel2 (AUTHOR), Orme, Jacob J.2 (AUTHOR), Quevedo, J. Fernando2 (AUTHOR), Kizilbash, Sani H.2 (AUTHOR), Kwon, Eugene D.3,4 (AUTHOR), Johnson, Geoffrey B.1,3 (AUTHOR), Johnson, Derek R.1 (AUTHOR), Sartor, Oliver1,2,3 (AUTHOR), Kendi, Ayse Tuba1 (AUTHOR)
Source: European Journal of Nuclear Medicine & Molecular Imaging. Jan2026, Vol. 53 Issue 2, p824-832. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16197070
DOI:10.1007/s00259-025-07447-0